|
MAP3K2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.21970000344885E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.97710000044071E-07 |
| Normal-vs-Stage2 |
1.60388000000067E-05 |
| Normal-vs-Stage3 |
4.74860000210242E-08 |
| Normal-vs-Stage4 |
3.30380000002073E-06 |
| Stage1-vs-Stage2 |
5.016000E-01 |
| Stage1-vs-Stage3 |
3.388800E-01 |
| Stage1-vs-Stage4 |
4.511600E-01 |
| Stage2-vs-Stage3 |
9.810800E-01 |
| Stage2-vs-Stage4 |
9.569600E-01 |
| Stage3-vs-Stage4 |
9.683200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.26870000353108E-08 |
| Normal-vs-AfricanAmerican |
3.325600E-02 |
| Normal-vs-Asian |
1.34009999996909E-06 |
| Caucasian-vs-AfricanAmerican |
2.128600E-01 |
| Caucasian-vs-Asian |
3.553400E-01 |
| AfricanAmerican-vs-Asian |
8.874000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.8230997801445E-10 |
| Normal-vs-Female |
2.71789999950478E-07 |
| Male-vs-Female |
5.372400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.44809999999851E-06 |
| Normal-vs-Age(41-60Yrs) |
4.10190004185296E-09 |
| Normal-vs-Age(61-80Yrs) |
5.49579999953309E-07 |
| Normal-vs-Age(81-100Yrs) |
1.593800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.493840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.925400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.550600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.248800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.934400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.929800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.850000E-01 |
| Classical-VS-Follicular |
5.355600E-02 |
| Classical-VS-Other |
9.447900E-02 |
| Classical-VS-Normal |
7.97749999947861E-07 |
| Tall-VS-Follicular |
5.521600E-01 |
| Tall-VS-Other |
1.227840E-01 |
| Tall-VS-Normal |
1.238190E-04 |
| Follicular-VS-Other |
3.406400E-01 |
| Follicular-VS-Normal |
2.06269999969422E-07 |
| Other-VS-Normal |
8.844300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.70870004204227E-09 |
| Normal-vs-N1 |
1.58791999999019E-05 |
| N0-vs-N1 |
8.388400E-01 |
|
|
